Hesperidin Dosage Guide: Protocols, Calculator & Safety
Everything you need to know about Hesperidin dosing — protocols, safety, and where to buy.
Dosage Calculator
Calculate exact dosing for Hesperidin.
Dosing Protocols
Beginner Protocol (first 6–8 weeks): The beginner entry point for hesperidin is simply food — one orange per day with the pith attached (NOT juice, which discards the pith that contains most of the hesperidin), or 250–500 mL of fresh-squeezed orange juice daily. This delivers roughly 40–100 mg of hesperidin per day and provides a clean introduction to the flavonoid without any supplement commitment. For users who want to supplement and have a specific indication (mild venous symptoms, borderline blood pressure, endothelial function concerns), start with 500 mg/day of 2S-hesperidin (Cardiose) as a single morning dose with breakfast. This form has 3–4x better bioavailability than native hesperidin glycoside, and 500 mg is at the low end of the clinical-trial dose range, so tolerability is essentially universal. Take it consistently for 6–8 weeks before evaluating. Expected outcomes: no dramatic acute changes, but possibly better exercise tolerance, reduced leg-heaviness at the end of the day, and small improvements in seated blood pressure if yours is elevated. Home monitoring: if you are targeting blood pressure, take seated BP readings every morning and every evening for a week before starting, then repeat at week 6 and week 8. A 2–4 mmHg reduction in systolic is the typical signal. If you see no change, either you are a non-responder (roughly 1 in 3 based on the literature) or the indication is not hesperidin-responsive; consider L-citrulline or dietary nitrate as alternatives.
Intermediate Protocol (weeks 8–24, symptomatic venous insufficiency, hemorrhoids, or exercise performance): If you have CEAP C2–C4 chronic venous insufficiency (visible varicose veins with symptoms, edema, skin changes), C2–C3 is where MPFF/Daflon has its strongest evidence and should be combined with 20–30 mmHg graduated compression stockings and calf-pump exercise. Dosing is 500 mg MPFF twice daily with meals for 2–3 months, then reassess. Symptom scales like the VCSS (Venous Clinical Severity Score) or a simple 0–10 leg-heaviness rating track progress well. If your primary indication is symptomatic hemorrhoidal disease, the protocol is MPFF 500 mg three times daily for the first 4 days during an acute flare, then 500 mg twice daily for 3 months, combined with fiber (30+ g/day), increased water intake, and topical hygiene. This is the dosing regimen that has the strongest evidence in the hemorrhoid meta-analyses.
For exercise performance in endurance sports (cycling, running, rowing), the intermediate protocol is 500 mg/day 2S-hesperidin (Cardiose) taken year-round with an optional 1000 mg/day loading dose for 4 weeks before a target event. Combine with a full ergogenic stack: creatine 5 g/day, beta-alanine 3–6 g/day, dietary nitrate on competition days, caffeine 3–6 mg/kg pre-event. The hesperidin performance signal is small (2–5%) and may be at the margin of detection in any individual athlete, but the safety profile is perfect and the cost is low.
For borderline hypertension (130–140 systolic) or documented endothelial dysfunction on vascular ultrasound, the intermediate stack is 2S-hesperidin 500 mg/day + L-citrulline 3–6 g/day + dietary nitrate (beetroot juice 70 mL concentrate daily or 300–500 g cooked beets weekly) + magnesium glycinate 300–400 mg/day. This is a well-evidenced blood-pressure stack with minimal side effects, and it can be layered under a first-line antihypertensive (ACE inhibitor or calcium channel blocker) if your clinician prescribes one.
Advanced Protocol (6+ months, stacked with other flavonoids, specific vascular/metabolic goals): Advanced users treat hesperidin as the vascular/endothelial pillar of a multi-flavonoid polyphenol stack, with the 2S-hesperidin form at 500–1000 mg/day baseline, combined with quercetin 500 mg, apigenin 50–100 mg, and either epigallocatechin gallate 300 mg (away from iron-containing meals) or pterostilbene 100–150 mg. This hits flavonol, flavone, flavanone, and either catechin or stilbene subclasses, maximizing the subclass diversity of the polyphenol signal. Layer in NAD+ precursors (NMN 500–1000 mg or NR 300–600 mg), L-citrulline 6 g, and dietary nitrate for the full vascular-longevity stack. Monitor quarterly with basic metabolic panel, lipid panel, hs-CRP, HbA1c, and home BP; consider an ApoB/Lp(a) panel annually.
For athletes with chronic venous insufficiency or superficial varicose veins who continue training hard, the advanced protocol combines MPFF 500 mg BID year-round + horse chestnut 300 mg BID standardized to 16–20% escin + pycnogenol 100 mg BID for maximal venous-tone and endothelial support, plus 20–30 mmHg compression socks during long training sessions and flights. Reassess ultrasound annually and consider endovenous ablation if reflux progresses.
For research-oriented users interested in the hesperidin exercise-performance signal, consider cycling between 500 mg/day (baseline) and 1000 mg/day (for 4–6 weeks before target events), with a 2-week washout between high-dose cycles. The evidence for cycling vs steady dosing is limited, but a pulse-dose approach may help preserve any receptor-level adaptation and reduce the ongoing cost of supplementation.
Measurement for advanced users. Objective vascular measurements — brachial-artery flow-mediated dilation on ultrasound, pulse-wave velocity via the SphygmoCor device or equivalent, central aortic pressure estimation, venous duplex ultrasound — are the gold-standard ways to measure hesperidin's effects on vascular function. These are available in cardiology clinics and some functional-medicine practices. Less expensive surrogates include home BP monitoring (2x/day for 2 weeks before and after a 12-week supplement trial) and self-rated leg heaviness/edema on a 0–10 scale, both tracked with a simple spreadsheet or app. If you have established CVI, a handheld Doppler or a formal duplex ultrasound every 12–24 months will tell you whether MPFF is holding disease progression.
Commonly Stacked With
Hesperidin stacks productively with other flavonoids and with vascular-health compounds, and its vascular niche makes it one of the easier polyphenols to stack rationally around a specific outcome goal.
Vascular/endothelial stack. The natural partners are L-citrulline (2–6 g/day, direct NO substrate), beet root / dietary nitrate (6–8 mmol/day nitrate as vegetable juice or supplement), and pycnogenol (100–200 mg/day French maritime pine bark, shares NO-enhancing and endothelial-protective activity). Hesperidin 500 mg of 2S-hesperidin or 1000 mg MPFF plus 3–6 g citrulline plus 5–7 mmol dietary nitrate is a well-evidenced stack for flow-mediated dilation and exercise performance. Add magnesium glycinate 300–400 mg and potassium from food for the blood-pressure-focused version.
Venous insufficiency stack. For chronic venous insufficiency, hemorrhoids, or lower-limb edema, the evidence-based stack is MPFF 500 mg BID (or pure hesperidin 500 mg BID + diosmin 450 mg BID if you can source both), plus compression stockings (20–30 mmHg for mild-moderate CVI), plus 30+ g/day dietary fiber (for hemorrhoids specifically). Add horse chestnut seed extract standardized to 16–20% escin at 300 mg BID if single-agent MPFF is inadequate — the horse chestnut–MPFF combination has an additive vein-tone benefit and is used routinely in European phlebology. Do NOT add high-dose fish oil on top of this stack if you have severe varicose veins or active hemorrhoidal bleeding without talking to your doctor, because of the theoretical bleeding additivity at high polyphenol intakes.
Flavonoid-comprehensive stack. For users who want a broad polyphenol intake for general anti-inflammatory and cardiovascular purposes, layering flavonoids from different subclasses works well because they hit distinct targets: quercetin 500 mg (flavonol, mast-cell + senolytic), hesperidin 500 mg of 2S-hesperidin (flavanone, vascular), apigenin 50–100 mg (flavone, CD38 inhibition + GABA-A), and epigallocatechin gallate 150–300 mg (catechin, cardiovascular + metabolic). Stagger the EGCG away from iron-containing meals. All four can be taken together with a meal; this is essentially a "Sirtfood Diet" supplement cluster.
Exercise performance stack. For endurance athletes, 2S-hesperidin 500 mg/day (Cardiose) plus beta-alanine 3–6 g/day plus beetroot / nitrate on competition days, plus caffeine 3–6 mg/kg pre-event, gives you four different mechanisms (endothelial NO, muscle buffering, mitochondrial efficiency, adenosine antagonism) with minimal interaction risk. Add creatine 5 g/day as the foundational ergogenic.
NAD+/longevity stack. Hesperidin is not a primary NAD+ or autophagy intervention, but it complements the flavonoid NAD+ preservation story by supporting vascular health during the age-related decline in endothelial function. A reasonable NAD+-plus-vascular stack is NMN or NR 500 mg, plus apigenin 50 mg (for CD38 inhibition), plus trans-resveratrol or pterostilbene 100–150 mg (for SIRT1), plus 2S-hesperidin 500 mg (for endothelial function). This is a premium polyphenol stack and gets expensive — the minimum effective version is NMN + hesperidin.
What NOT to stack: Do not combine hesperidin with bergamot/bergamottin-rich supplements or grapefruit-juice-concentrate products if you take CYP3A4-metabolized drugs — the flavonoids themselves are fine, but bergamottin adds genuine CYP3A4 inhibition that complicates statin and calcium-channel-blocker dosing. Do not combine very high-dose hesperidin (>2 g/day) with high-dose aspirin, warfarin, or chronic NSAIDs without clinician supervision.
Side Effects & Safety
Contraindications
Hesperidin is one of the safest polyphenol supplements in the BodyHackGuide catalog, and absolute contraindications are few. The main cautions: **Citrus allergy.** If you have a documented citrus allergy (orange, lemon, grapefruit, tangerine), skin-test a small dose first or avoid hesperidin supplements entirely. The hesperidin molecule is not a common allergen, but most commercial products are derived from orange peel and may contain trace amounts of allergenic citrus proteins. **Active bleeding or bleeding disorders.** At very high doses (>2 g/day) combined with aspirin, NSAIDs, warfarin, DOACs, or fish oil, hesperidin has a theoretical additive bleeding risk. If you have a bleeding disorder (hemophilia, von Willebrand disease, severe thrombocytopenia), active GI bleeding, or active hemorrhagic stroke, do not exceed dietary intake levels without hematology consultation. Note: the phlebology literature explicitly uses MPFF during acute hemorrhoidal bleeding, which is the opposite of the typical bleeding contraindication, so this caution is nuanced — the beneficial venotonic effect in hemorrhoids likely outweighs any small additive anti-platelet effect. **Anticoagulation.** If you take warfarin, adding or stopping hesperidin supplementation should prompt an INR check 2–3 weeks later. The interaction is probably minimal but worth monitoring. DOAC users do not need formal monitoring but should mention the supplement to their prescriber. Aspirin and NSAID users can take hesperidin without special monitoring at typical doses (500–1000 mg/day). **Pregnancy and lactation.** Dietary citrus intake is universally safe. Pharmacologic supplementation (500+ mg/day) has not been formally evaluated in pregnancy in the US/Canadian regulatory context, though MPFF is commonly prescribed in European phlebology for pregnancy-related varicose veins and lower-limb edema with a long safety record. Discuss with your obstetrician before starting supplemental hesperidin during pregnancy. Lactation: trace amounts of hesperidin appear in breast milk after citrus intake, with no documented harm to infants; supplemental hesperidin during lactation is probably fine but has not been systematically evaluated. **Pediatric use.** MPFF is used in European pediatric practice with no meaningful safety signal. In other regions, pediatric supplementation should be clinician-supervised. Dietary citrus intake is clearly appropriate for all non-allergic children. **Liver and kidney disease.** Hesperidin is not hepatotoxic or nephrotoxic at supplemental doses and is not a meaningful CYP450 inhibitor at typical doses. Patients with established liver or kidney disease do not have specific contraindications but should include hesperidin in their full medication and supplement review with their hepatologist or nephrologist. **Drug interactions beyond anticoagulants.** Hesperidin weakly inhibits P-glycoprotein and OATP1A2 in some preclinical models, which could theoretically increase blood levels of narrow-therapeutic-index drugs that are P-gp or OATP substrates (fexofenadine, aliskiren, digoxin, some statins). At typical supplemental doses the clinical magnitude is probably minimal, but if you take one of these drugs, take hesperidin at a different time of day (4+ hour gap) as a simple hedge. Orange juice interacts with fexofenadine and aliskiren via OATP1A2 inhibition and is a more clinically relevant interaction than hesperidin supplementation itself. **Surgery.** Stop high-dose hesperidin supplementation (>500 mg/day) 7 days before major surgery as a precaution against theoretical bleeding additivity, though the absolute risk is very low. MPFF for CVI is generally continued through elective surgery in European practice with no bleeding concerns noted in the surgical literature. **Concurrent with aggressive platelet inhibition.** For users on dual antiplatelet therapy (aspirin + clopidogrel, aspirin + ticagrelor) after stent placement or ACS, limit hesperidin to ≤500 mg/day and avoid concurrent high-dose fish oil unless specifically cleared by your cardiologist. **Not contraindicated but commonly confused:** Hesperidin is NOT the same as bergamot, bergapten, or bergamottin, even though these are all citrus-derived compounds. The grapefruit-juice interaction that affects CYP3A4-metabolized drugs is NOT driven by hesperidin but by furanocoumarins like bergamottin. Sweet oranges (the source of most commercial hesperidin) contain essentially no furanocoumarins, so hesperidin supplements do not carry the grapefruit-juice drug-interaction profile. However, bergamot-orange extract supplements DO contain bergamottin and DO interact with CYP3A4 substrates — read labels carefully. **Red flags that warrant stopping hesperidin.** Unexplained easy bruising or prolonged bleeding times, new or worsening allergic symptoms (rash, urticaria, angioedema), unexplained GI bleeding, or any worsening of the underlying venous or cardiovascular condition you are treating. In any of these scenarios, stop the supplement and consult your clinician.
Additional Notes
Hesperidin dosing depends entirely on the form you choose, because bioavailability varies dramatically across formulations. The four commercially available forms, roughly ranked by per-milligram bioavailability:
-
MPFF (Daflon 500 / micronized purified flavonoid fraction) — 500 mg tablets containing 450 mg diosmin + 50 mg hesperidin, micronized to <2 μm particle size. Standard dose is 1 tablet BID (1000 mg/day) for chronic venous insufficiency; 2 tablets TID for 4 days then 2 BID for acute hemorrhoidal flares. Prescription-only in most countries, OTC in some. Absorption is much higher than non-micronized diosmin or hesperidin. Highest clinical evidence base, particularly for venous/phlebology indications.
-
2S-hesperidin (hesperidin-2-glucoside, Cardiose, G-hesperidin) — enzymatically glucosidase-treated hesperidin, roughly 3–4x more bioavailable than native hesperidin glycoside. Standard dose 500 mg/day (single morning dose or split BID). This is the form with the strongest exercise-performance and endothelial-function evidence in the recent literature (Martinez-Noguera 2019, Salden 2016). Available as Cardiose ingredient from HealthTech BioActives in commercial products like Forte Hesperidin by Now Foods or as standalone Cardiose 500 mg capsules from several brands.
-
Hesperidin phytosome (Bio-Hesp / Eriomin) — hesperidin bound to phosphatidylcholine to enhance absorption. 500–1000 mg/day typical. Evidence base smaller than for 2S-hesperidin but mechanism and safety are similar.
-
Native hesperidin glycoside — standard 500 mg tablets of unprocessed hesperidin. Cheapest but worst-absorbed. Requires 1000 mg/day minimum to achieve serum levels comparable to 500 mg 2S-hesperidin. Use native hesperidin only if you cannot source or afford the enhanced forms.
Timing. Take with meals to slow gastric emptying, improve emulsification (hesperetin aglycone is lipophilic), and reduce any theoretical GI irritation. For MPFF in venous insufficiency, morning and evening dosing is standard. For 2S-hesperidin in exercise performance, take the main dose in the morning; an additional 250 mg dose 60–90 minutes before training is supported by the pharmacokinetics (Cmax of 2S-hesperidin is roughly 1–3 hours post-dose, earlier than native hesperidin's 5–7 hour Tmax).
Duration and cycling. Hesperidin/MPFF is typically used continuously rather than cycled. The Daflon/MPFF safety database covers multi-year continuous use without cumulative toxicity. For exercise performance, a 4–8 week pre-season loading block at 1000 mg/day with maintenance at 500 mg/day during the competitive season is a reasonable pattern. If you are using hesperidin for blood pressure or endothelial function, plan on continuous use — stopping will gradually reverse the endothelial adaptations over 4–8 weeks.
Ceiling dose. The highest dose used in clinical trials is 1500 mg/day of native hesperidin (roughly equivalent to 500 mg of 2S-hesperidin) without meaningful adverse-event signals. MPFF has been used at 3000 mg/day during acute hemorrhoidal flares for 4 days. There is no clinically useful benefit to exceeding 1000 mg/day 2S-hesperidin chronically — response curves flatten by 500–900 mg.
Food-based dosing. A large orange (peeled with pith retained) delivers roughly 40–75 mg hesperidin. 250 mL fresh-squeezed orange juice delivers 30–60 mg. Lemons and tangerines are richer on a per-weight basis but harder to eat in volume. Dried orange peel or candied orange peel is very high in hesperidin, but the calorie load limits practical intake. A diet with 1–2 citrus servings per day provides perhaps 80–150 mg hesperidin, which is below the clinical-trial threshold but still meaningful for cardiovascular-risk reduction at the population level (as shown in Mediterranean-diet cohort data).
Frequently Asked Questions
What is the recommended Hesperidin dosage?
Dosage for Hesperidin varies by protocol. Consult a qualified healthcare provider.
How often should I take Hesperidin?
Administration frequency depends on the specific protocol. Consult current research literature.
Does Hesperidin need to be cycled?
Cycling requirements depend on the protocol. Follow established research guidelines.
What are Hesperidin side effects?
Hesperidin has one of the best safety profiles of any polyphenol supplement on BodyHackGuide, with decades of prescription-grade use in European phlebology producing no ceiling-dose toxicity, no meaningful drug interactions at typical doses, and no teratogenic signals at dietary intakes. The most commonly reported side effects in clinical trials of MPFF (1000 mg/day) and 2S-hesperidin (500–900 mg/day) are mild and GI-predominant: occasional dyspepsia, nausea, loose stools, and flatulence, each reported in <5% of participants and generally indistinguishable from placebo rates. Allergic reactions to hesperidin supplements are very rare but do occur, usually as skin rash or urticaria. People with documented citrus allergies should be cautious about high-dose hesperidin supplementation, though the hesperidin molecule itself is not a common allergen — most citrus allergies are driven by LTPs (lipid transfer proteins) or profilins, not flavonoids. If you develop a rash after starting a hesperidin supplement, discontinue and consider an alternative flavonoid. Bleeding and anticoagulation: at typical supplemental doses (500–1000 mg/day), hesperidin has minimal platelet-inhibitory activity and the clinical bleeding signal is essentially zero in the phlebology literature. At very high intakes (>2 g/day), or when combined with aspirin, fish oil, other anti-platelet agents, or warfarin, there is a theoretical additive bleeding risk. If you take warfarin, discuss any new polyphenol supplement with your anticoagulation clinic and check INR 2–3 weeks after starting. People on DOACs (apixaban, rivaroxaban, dabigatran, edoxaban) do not need INR monitoring but should still mention the supplement to their prescriber. Pregnancy and lactation: dietary intake of citrus fruit and juice during pregnancy is universally considered safe and probably beneficial. Supplemental hesperidin at pharmacologic doses during pregnancy has not been formally studied and should be discussed with an obstetrician — MPFF is commonly prescribed in European phlebology for pregnancy-related varicose veins and lower-limb edema, with a long safety track record, though this is off-label in most of the world outside Europe. Dietary intake via citrus fruit is clearly fine; supplemental hesperidin at 500–1000 mg/day is probably fine but has not been systematically evaluated in pregnancy. Drug interactions: hesperidin does not meaningfully inhibit CYP3A4 at typical supplemental doses (the grapefruit-juice interaction that blocks CYP3A4 is driven by furanocoumarins like bergamottin and 6',7'-dihydroxybergamottin, not by hesperidin itself, and sweet oranges contain essentially no furanocoumarins). However, hesperidin has been shown to weakly inhibit P-glycoprotein and OATP1A2 in some preclinical studies, and at very high intakes this could theoretically increase absorption of P-gp and OATP substrates (fexofenadine, aliskiren, some statins). The clinical magnitude is probably minimal, but if you are on a narrow-therapeutic-index drug and take high-dose hesperidin, space the doses by 2–4 hours as a simple hedge. Orange juice itself can interact with several drugs via OATP1A2 inhibition (the so-called "orange juice effect" on fexofenadine), though this is a transient and dose-dependent effect. Kidney and liver: hesperidin has no known nephrotoxicity or hepatotoxicity at supplemental doses. The Daflon/MPFF safety database covers millions of patient-years at 1000 mg/day and has not produced a meaningful safety signal. Hesperidin is not on the HDS (herbal and dietary supplement) hepatotoxicity watchlist and does not show up in the LiverTox database as a concerning supplement, in contrast to [EGCG](/compound/egcg) at very high doses. Pediatric use: MPFF is used in European pediatric practice for chronic venous insufficiency and hemorrhoids with no meaningful safety signals, but pediatric supplementation should be supervised. Dietary citrus intake is obviously appropriate for children of any age who are not allergic. Rare adverse events worth noting: isolated case reports of headache, dizziness, and palpitations with MPFF, none rising above background rates. No signal for cardiac arrhythmia, QT prolongation, hepatic injury, renal injury, hematologic toxicity, or carcinogenicity in the published safety database.
Where can I buy Hesperidin?
Visit our vendor directory to find trusted sources for Hesperidin.
Free 2026 Peptide Cheat Sheet — 50 pages, PDF
Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.
